|
---|
Category:Letter
MONTHYEARML24128A2162024-05-0707 May 2024 Shine Technologies, LLC, Submittal of Annual Financial Report ML24047A0392024-02-16016 February 2024 Shine Technologies, LLC - Periodic Report Required by the License Conditions in Section 3.D.(1) of CPMIF-001 ML23229A0202023-08-17017 August 2023 Periodic Report Required by the License Conditions in Section 3.D.(1) of CPMIF-001 ML23087A2272023-05-0505 May 2023 Shine Technologies, LLC - Issuance of Amendment No. 4 to Construction Permit No. CPMIF-001 for the Receipt and Possession of Contained Special Nuclear Material ML23086C0502023-04-27027 April 2023 Shine Technologies, LLC - Letter, Environmental Assessment and Finding of No Significant Impact ML23088A3382023-04-0505 April 2023 Shine Technologies, LLC - Review of the Physical Security Plan in Support of an Operating License for a Medical Radioisotope Production Facility ML23010A1982023-02-24024 February 2023 Shine Technologies, LLC - Letter: Safety Evaluation Report for the Shine Medical Radioisotope Production Facility Operating License Application ML23048A2442023-02-17017 February 2023 Shine Technologies, LLC Request to Amend Construction Permit No. CPMIF-001 Response to Request for Additional Information ML23010A2382023-02-0303 February 2023 Shine Technologies, LLC - Individual Notice of Consideration FRN Letter ML23034A1872023-02-0303 February 2023 Shine Medical Technologies, LLC Notice of Availability of Environmental Impact Statement Supplement Related to the Operating License for the Shine Medical Isotope Production Facility (Docket Number: 50-608) ML23023A0922023-02-0202 February 2023 Notice of Availability of the Environmental Impact Statement Supplement Related to the Operating License for the Shine Medical Isotope Production Facility ML23023A0942023-02-0202 February 2023 Notice of Availability of the Environmental Impact Statement Supplement Related to the Operating License for the Shine Medical Isotope Production Facility ML23023A0862023-02-0202 February 2023 Notice of Availability of the Environmental Impact Statement Supplement Related to the Operating License for the Shine Medical Isotope Production Facility ML23024A1682023-02-0101 February 2023 Letter to Ken Westlake, EPA Region 5 - Issuance of Final EIS Supplement Related to the Operating License ML22287A1852023-02-0101 February 2023 Shine Technologies, LLC Regulatory Report on the Audit of Phased Startup Operations Application Supplement ML23024A1742023-02-0101 February 2023 Dr. Gregory Piefer, Chief Executive Officer - Issuance of Final EIS Supplement Related to the Operating License ML22308A2332023-01-0909 January 2023 Shine Technologies LLC - Regulatory Audit Report for Chapter 8 - Irradiation Facility and Radioisotope Production Facility Electrical Power Systems ML22347A2142023-01-0404 January 2023 Shine Technologies LLC - Regulatory Audit Report for I&C Combined Sessions ML22356A1932022-12-22022 December 2022 Shine Technologies, LLC Application for an Operating License - Response to Request for Confirmatory Information ML22347A1772022-12-14014 December 2022 Shine Technologies LLC - Regulatory Audit Report for Programmable Logic Lifecycle ML22301A1492022-12-0707 December 2022 Shine Technologies, LLC - Regulatory Audit Report for Chapter 13 - Accident Analysis and Criticality Safety ML22322A2122022-12-0202 December 2022 Shine Medical Technologies - Cybersecurity Audit Summary Report ML22322A2232022-12-0202 December 2022 Shine Medical Technologies - Fire Protection Audit Summary Report ML22348A0672022-12-0101 December 2022 Shine Technologies, LLC - Request for Confirmatory Information Related to Instrumentation and Control Systems ML22335A5722022-12-0101 December 2022 Shine Technologies, LLC Application for an Operating License Response to Request for Confirmatory Information ML22292A3192022-11-30030 November 2022 Shine Medical Technologies, LLC Issuance of Order and Amendment No. 3 to Construction Permit No. CPMIF-001 ML22318A1782022-11-14014 November 2022 Shine Technologies, LLC Application for an Operating License Response to Request for Confirmatory Information ML22304A1262022-10-31031 October 2022 Shine Technologies, LLC Application for an Operating License Response to Request for Confirmatory Information ML22279A9512022-10-0606 October 2022 Shine Technologies, LLC Request to Amend Construction Permit No. CPMIF-001 ML22271A9632022-09-28028 September 2022 Shine Technologies, LLC Application for an Operating License Supplement No. 31 Revision to the Phased Startup Operations Application Supplement ML22263A3442022-09-20020 September 2022 Shine Technologies, LLC Application for an Operating License - Response to Request for Additional Information ML22263A0272022-09-19019 September 2022 Shine Technologies, LLC - Application for an Operating License - Response to Request for Confirmatory Information ML22220A2612022-09-12012 September 2022 Shine Technologies LLC - Regulatory Report on the Audit Chapter 14, Technical Specifications ML22251A3272022-09-0808 September 2022 Shine Technologies, LLC Application for an Operating License Revision 1 of Shine Response to Requests for Additional Information 7-38, 7-40, and 7-48 ML22249A1252022-08-31031 August 2022 Shine Technologies, LLC Final Safety Analysis Report - Application for an Operating License Supplement No. 30, Cover Letter ML22105A1102022-08-26026 August 2022 Shine Medical Technologies LLC - Request for Additional Information Related to the OGC Review of Phrase Approach ML22061A2122022-08-24024 August 2022 Shine Medical Technologies LLC - Regulatory Audit Plan for Phased Approach - Session 1 ML22187A1342022-08-0101 August 2022 Shine Technologies, LLC - Update to Operating License Application Technical Review Schedule ML22213A0492022-08-0101 August 2022 Shine Technologies, LLC Application for an Operating License Response to Request for Confirmatory Information ML22206A2082022-07-27027 July 2022 Shine Medical Technologies, LLC - Request for Confirmatory Information Related to Radiation Protection Program and Waste Management ML22207A0062022-07-26026 July 2022 Shine Technologies, LLC Application for an Operating License Supplement No. 29 ML22202A4492022-07-21021 July 2022 Shine Technologies, LLC Operating License Application Supplement No. 28 - Submittal of a Revision to the Shine Emergency Plan ML22188A2412022-07-14014 July 2022 Meeting with Shine Medical Technologies, LLC (EPID No. L-2019-NEW-0004), to Discuss Development of Shine'S Cybersecurity Program for It'S Medical Isotope Production Facility ML22175A0392022-07-11011 July 2022 Letter to Reid Nelson, Achp Notice of Availability and Request for Comments on the Draft EIS Supplement Related to the Operating License for the Shine Facility ML22175A0542022-07-0808 July 2022 Letter to Gregory Piefer - Notice of Availability of the Draft EIS Supplement Related to the Operating License for the Shine Medical Isotope Production Facility ML22175A0912022-07-0808 July 2022 Notice of Availability and Request for Comments on the Draft Environmental Impact Statement Supplement Related to the Operating License for the Shine (Multiple Tribal Letters) ML22175A0772022-07-0808 July 2022 Letter to Daina Penkiunas - Notice of Availability and Request for Comments on the Draft EIS Supplement Related to the Operating License for the Shine Facility ML22175A0632022-07-0808 July 2022 Letter to Ken Westlake, EPA Region 5 - Notice of Availability and Request for Comments on the Draft EIS Supplement Related to the Operating License for the Shine Facility ML22188A1942022-07-0707 July 2022 Shine Technologies, LLC, Application for an Operating License Supplement No. 27 ML22188A0562022-07-0707 July 2022 Shine Technologies, LLC Operating License Application Supplement No. 26 Submittal of a Revision to the Shine Material Control and Accounting Plan 2024-05-07
[Table view] |
Text
UNITED STATES NUCLEAR REGULATORY COMMISSION WASHINGTON, D.C. 20555-0001 November 24, 2019 Gregory Piefer, Ph.D.
Chief Executive Officer SHINE Medical Technologies, LLC 101 E. Milwaukee Street, Suite 600 Janesville, WI 53545
SUBJECT:
SHINE MEDICAL TECHNOLOGIES, LLC - NOTICE OF INTENT TO SUPPLEMENT THE FINAL ENVIRONMENTAL IMPACT STATEMENT FOR THE PROPOSED MEDICAL ISOTOPE PRODUCTION FACILITY AND CONDUCT SCOPING (DOCKET NUMBER: 50-608)
Dear Dr. Piefer:
The U.S. Nuclear Regulatory Commission (NRC) staff received the SHINE Medical Technologies, LLC (SHINE) application dated July 17, 2019 (Agencywide Documents Access and Management System (ADAMS) Accession No. ML19211C143), for an operating license for the proposed SHINE Medical Isotope Production Facility in Janesville, Wisconsin. As part of the application, SHINE submitted a supplement to its environmental report. The NRC staff accepted the SHINE operating license application for docketing on October 8, 2019 (ADAMS Accession No. ML19276D411). This letter provides information related to the next steps in the NRC staffs environmental review of the application.
The NRC staff has prepared a notice of intent (NOI) informing the public that the NRC intends to gather information and prepare a supplement to the Environmental Impact Statement for the Construction Permit for the SHINE Medical Radioisotope Production Facility (NUREG-2183).
Enclosed is a copy of the NOI, which has been forwarded to the Office of the Federal Register for publication.
Pursuant to Title 10 of Code of Federal Regulations (10 CFR), Section 51.28, SHINE is invited to participate in the environmental scoping process. As discussed in the enclosed notice, the NRC staff is providing stakeholders and the public with the opportunity to participate in the scoping process. For this review, one scoping meeting will be held on December 12, 2019, from 6:00 p.m. to 8:00 p.m. at The Celtic House at Glen Erin Golf Club, 1417 W Airport Rd, Janesville, Wisconsin 53546. There will be an open house one hour before the meeting for members of the public to meet with the NRC staff, sign in, and indicate if they would like to speak at the meeting. The NRC staff will present an overview of the safety and environmental review processes and will explain how these processes will be conducted for this review.
However, the main objectives of this meeting are to describe the environmental review process and receive public comments on the appropriate scope and content to be considered in the staffs review.
G. Piefer 2 A copy of the meeting notice will be posted to NRCs website at https://www.nrc.gov/pmns/mtg.
In the interim, should you have any questions regarding the scoping meeting, please contact the NRCs Senior Environmental Project Manager, Ms. Jennifer Davis, at 301-415-3835 or via e-mail at Jennifer.Davis@nrc.gov.
Sincerely,
/RA/
Robert B. Elliott, Chief Environmental Review License Renewal Branch Division of Rulemaking, Environmental, and Financial Support Office of Nuclear Material Safety and Safeguards Docket No. 50-608
Enclosure:
Federal Register Notice cc w/encl.:
See next page
G. Piefer cc w/encl.:
Jeff Bartelme Test, Research and Training Licensing Manager Reactor Newsletter SHINE Medical Technologies, Inc. Attention: Amber Johnson 101 E. Milwaukee Street, Suite 600 Dept of Materials Science Janesville, WI 53545 and Engineering University of Maryland Christopher Landers 4418 Stadium Drive Director, Office of Conversion College Park, MD 20742-2115 National Nuclear Security Administration, NA 23 Mark Freitag U.S. Department of Energy City Manager 1000 Independence Ave SW P.O. Box 5005 Washington, DC 20585 Janesville, WI 53547-5005 Mark Paulson Supervisor Field Office Supervisor Radiation Protection Section U.S. Fish and Wildlife Service Wisconsin Department of Health Services Ecological Services Field Office P.O. Box 2659 2661 Scott Tower Drive Madison, WI 53701-2659 New Franken, WI 54229 Shelley Warwick Bill McCoy Environmental Analysis Specialist- 1326 Putnam Avenue South Team Janesville, WI 53546 Wisconsin Department of Natural Resources Alfred Lembrich 3911 Fish Hatchery Road 541 Miller Avenue Fitchburg, WI 53711 Janesville, WI 53548
ML19326B098 (Package), ML19326B085 (Letter),
ML19311C521 (Federal Register Notice)
- concurrence via e-mail OFFICE NMSS/REFS/ERMB NMSS/REFS/ENRB NRR/DANU/NPLB OGC NMSS/REFS/ENRB NMSS/REFS/ENRB NAME *AWalker-Smith JDavis *SLynch *RAugustus JDavis RElliott DATE 11/06/19 11/22/19 11/21/19 11/21/19 11/26/19 11/27/19